Insights Archive

Filter:

Read more

Meet the Founders

Meet the Founders: Cheerag Shirodaria, CEO and Charalambos Antoniades, CSO, Caristo Diagnostics Cardiovascular disease is the world’s biggest killer, accounting…

Read more

BHF researchers secure EU approval for new AI heart attack prediction technology

Research funded by us has led to EU-approved artificial intelligence (AI) technology that can identify people at high risk of…

Read more

AI spots heart risk hidden on scans

The NHS is using new technology to warn patients most in danger of an attack — up to nine years…

Read more

Assessing Cardiovascular Risk by Using the Fat Attenuation Index in Coronary CT Angiography

Coronary CT angiography (CCTA) has evolved into a first-line diagnostic test for the investigation of chest pain. Despite advances toward…

Read more

Fat attenuation index (FAI): a paradigm shift in cardiology.

Medscape Brazil have featured Dr Cheerag Shirodaria for his work within the industry. Cheerag Shirodaria is a Cardiologist and Honorary…

Read more

Anti-Inflammation Heralds the Future of CV Medicine

From CANTOS to COLCOT to COPS to LoDoCo2: Dr. Ridker presents the lessons from these trials with anti-inflammatory treatment, in…

Read more

The Year in Cardiovascular Medicine 2020: Digital Health and Innovation

Advances in digital health and particularly in artificial intelligence (AI) have led us very close to the true implementation of…

Read more

Current Evidence and Recommendations for Coronary CTA First in Evaluation of Stable Coronary Artery Disease

In the United States, functional imaging is the most commonly used method to diagnose potentially obstructive coronary artery disease (CAD) in patients…